{"id":39633,"date":"2024-11-04T09:30:45","date_gmt":"2024-11-04T08:30:45","guid":{"rendered":"https:\/\/digidem-bayern.de\/?p=39633"},"modified":"2025-01-14T09:15:14","modified_gmt":"2025-01-14T08:15:14","slug":"neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt","status":"publish","type":"post","link":"https:\/\/digidem-bayern.de\/en\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/","title":{"rendered":"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt?"},"content":{"rendered":"

Echte Hilfe f\u00fcr Betroffene oder medialer Hype – was k\u00f6nnen wir von den neuen Medikamenten zur Behandlung der Alzheimer-Erkrankung wirklich erwarten? Weltweit f\u00fchren Fachexperten kontroverse Diskussionen \u00fcber die sogenannten monoklonalen Antik\u00f6rper, die f\u00fcr die Behandlung von leichten kognitiven Beeintr\u00e4chtigungen und Alzheimer-Demenz vorgesehen sind. Mit den Fakten aus der Forschung werden im Webinar die wichtigsten Fragen zum Thema beantwortet, darunter folgende Fragestellungen:<\/p>\n\n\n\n

* <\/strong>Wie gro\u00df ist die Wirksamkeit der neuen Medikamente?<\/p>\n\n\n\n

*<\/strong> Welche Nebenwirkungen gibt es?<\/p>\n\n\n\n

*<\/strong> Handelt es sich um eine Behandlung, die an einer Ursache der Alzheimer-Krankheit ansetzt?<\/p>\n\n\n\n

*<\/strong> Gibt es andere Therapieans\u00e4tze, die sich lohnen in Zukunft erforscht zu werden?<\/p>\n\n\n\n

*<\/strong> Mit welchen gesicherten Ma\u00dfnahmen l\u00e4sst sich der Alzheimer-Demenz vorbeugen?<\/p>\n\n\n\n

Der Arzt und Versorgungsforscher Prof. Dr. med. Elmar Gr\u00e4\u00dfel ist Leiter des Zentrums f\u00fcr Medizinische Versorgungsforschung am Universit\u00e4tsklinikum Erlangen und einer der Projektleiter von digiDEM Bayern. Er befasst sich als Forscher seit 35 Jahren mit dem Thema \u201eDemenz\u201c und ist Gr\u00fcndungsmitglied der Deutschen Alzheimer Gesellschaft e.V.<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Dienstag, 12.11.2024, 11:00 – 11:45 Uhr<\/strong><\/strong><\/h2>\n\n\n\n
\u00a0Melden Sie sich hier an<\/a><\/div><\/div><\/div>\n\n\n\n
\n
\n
\"\"

Jana R\u00fchl<\/h3>Wissenschaftliche Mitarbeiterin M.Sc.<\/span>

Moderation<\/p><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n

\n
\"\"

Anne Keefer<\/h3>Wissenschaftliche Mitarbeiterin M.Sc.<\/span>

Chatroom und Betreuung<\/p><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"

Echte Hilfe f\u00fcr Betroffene oder medialer Hype – was k\u00f6nnen wir von den neuen Medikamenten zur Behandlung der Alzheimer-Erkrankung wirklich erwarten? Weltweit f\u00fchren Fachexperten kontroverse Diskussionen \u00fcber die sogenannten monoklonalen Antik\u00f6rper, die f\u00fcr die Behandlung von leichten kognitiven Beeintr\u00e4chtigungen und Alzheimer-Demenz vorgesehen sind. Mit den Fakten aus der Forschung werden …<\/p>","protected":false},"author":12,"featured_media":39631,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"qubely_global_settings":"true","qubely_interactions":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[350],"tags":[13,406,1233,1235,1234,12,520,165,14,17,55,118,1217,819,564,94],"class_list":["post-39633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kommendes-webinar","tag-alzheimer","tag-alzheimer-demenz","tag-amyloid-hypothese","tag-antikoerper","tag-antikoerpertherapie","tag-demenz-2","tag-demenzerkrankung","tag-deutsche-alzheimer-gesellschaft","tag-digidem","tag-digidem-bayern","tag-digitales-demenzregister-bayern","tag-mci","tag-monoklonale-antikoerper","tag-nebenwirkungen","tag-uniklinikum-erlangen","tag-webinar"],"qubely_featured_image_url":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"portraits":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-540x320.jpg",540,320,true],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-300x169.jpg",300,169,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-768x432.jpg",768,432,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",18,10,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-622x350.jpg",622,350,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-734x350.jpg",734,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x300.jpg",520,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false]},"qubely_author":{"display_name":"Ilona H\u00f6rath","author_link":"https:\/\/digidem-bayern.de\/en\/author\/hoeratia\/"},"qubely_comment":1,"qubely_category":"Kommendes Webinar<\/a>","qubely_excerpt":"Echte Hilfe f\u00fcr Betroffene oder medialer Hype – was k\u00f6nnen wir von den neuen Medikamenten zur Behandlung der Alzheimer-Erkrankung wirklich erwarten? Weltweit f\u00fchren Fachexperten kontroverse Diskussionen \u00fcber die sogenannten monoklonalen Antik\u00f6rper, die f\u00fcr die Behandlung von leichten kognitiven Beeintr\u00e4chtigungen und Alzheimer-Demenz vorgesehen sind. Mit den Fakten aus der Forschung werden …","featured_image_urls_v2":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-300x169.jpg",300,169,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-768x432.jpg",768,432,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",18,10,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-622x350.jpg",622,350,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-734x350.jpg",734,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x300.jpg",520,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false]},"post_excerpt_stackable_v2":"

Echte Hilfe f\u00fcr Betroffene oder medialer Hype – was k\u00f6nnen wir von den neuen Medikamenten zur Behandlung der Alzheimer-Erkrankung wirklich erwarten? Weltweit f\u00fchren Fachexperten kontroverse Diskussionen \u00fcber die sogenannten monoklonalen Antik\u00f6rper, die f\u00fcr die Behandlung von leichten kognitiven Beeintr\u00e4chtigungen und Alzheimer-Demenz vorgesehen sind. Mit den Fakten aus der Forschung werden im Webinar die wichtigsten Fragen zum Thema beantwortet, darunter folgende Fragestellungen: * Wie gro\u00df ist die Wirksamkeit der neuen Medikamente? * Welche Nebenwirkungen gibt es? * Handelt es sich um eine Behandlung, die an einer Ursache der Alzheimer-Krankheit ansetzt? * Gibt es andere Therapieans\u00e4tze, die sich lohnen in Zukunft erforscht…<\/p>\n","category_list_v2":"Kommendes Webinar<\/a>","author_info_v2":{"name":"Ilona H\u00f6rath","url":"https:\/\/digidem-bayern.de\/en\/author\/hoeratia\/"},"comments_num_v2":"0 comments","yoast_head":"\nNeue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt? - digiDEM Bayern<\/title>\n<meta name=\"description\" content=\"Im Webinar "digiDEM Bayern Science Watch LIVE" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/digidem-bayern.de\/en\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt? - digiDEM Bayern\" \/>\n<meta property=\"og:description\" content=\"Im Webinar "digiDEM Bayern Science Watch LIVE" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/digidem-bayern.de\/en\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/\" \/>\n<meta property=\"og:site_name\" content=\"digiDEM Bayern\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/digiDEMBayern\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-04T08:30:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-14T08:15:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ilona H\u00f6rath\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ilona H\u00f6rath\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/\"},\"author\":{\"name\":\"Ilona H\u00f6rath\",\"@id\":\"\\\/#\\\/schema\\\/person\\\/0bc1494f46fc2a051c761322a80e0941\"},\"headline\":\"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt?\",\"datePublished\":\"2024-11-04T08:30:45+00:00\",\"dateModified\":\"2025-01-14T08:15:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/\"},\"wordCount\":198,\"commentCount\":0,\"publisher\":{\"@id\":\"\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/shutterstock_Lecanemab-Graessel-2237324545.jpg\",\"keywords\":[\"Alzheimer\",\"Alzheimer-Demenz\",\"Amyloid-Hypothese\",\"Antik\u00f6rper\",\"Antik\u00f6rpertherapie\",\"Demenz\",\"Demenzerkrankung\",\"Deutsche Alzheimer Gesellschaft\",\"digidem\",\"digidem Bayern\",\"Digitales Demenzregister Bayern\",\"MCI\",\"monoklonale Antik\u00f6rper\",\"Nebenwirkungen\",\"Uniklinikum Erlangen\",\"Webinar\"],\"articleSection\":[\"Kommendes Webinar\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/\",\"name\":\"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt? - digiDEM Bayern\",\"isPartOf\":{\"@id\":\"\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/shutterstock_Lecanemab-Graessel-2237324545.jpg\",\"datePublished\":\"2024-11-04T08:30:45+00:00\",\"dateModified\":\"2025-01-14T08:15:14+00:00\",\"description\":\"Im Webinar \\\"digiDEM Bayern Science Watch LIVE\\\" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/#primaryimage\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/shutterstock_Lecanemab-Graessel-2237324545.jpg\",\"contentUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/shutterstock_Lecanemab-Graessel-2237324545.jpg\",\"width\":1000,\"height\":563,\"caption\":\"Foto: Shutterstock\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/digidem-bayern.de\\\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/digidem-bayern.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt?\"}]},{\"@type\":\"WebSite\",\"@id\":\"\\\/#website\",\"url\":\"\\\/\",\"name\":\"digiDEM Bayern\",\"description\":\"Das digitale Demenzregister Bayern erforscht und verbessert die Angebotsstuktur f\u00fcr Menschen mit Demenz und deren Angeh\u00f6rige\",\"publisher\":{\"@id\":\"\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"\\\/#organization\",\"name\":\"digiDEM Bayern\",\"url\":\"\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png\",\"contentUrl\":\"https:\\\/\\\/digidem-bayern.de\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png\",\"width\":612,\"height\":357,\"caption\":\"digiDEM Bayern\"},\"image\":{\"@id\":\"\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/digiDEMBayern\\\/\",\"https:\\\/\\\/x.com\\\/digidem_bayern\",\"https:\\\/\\\/www.instagram.com\\\/digidem.bayern\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/digidem-bayern\\\/\"]},{\"@type\":\"Person\",\"@id\":\"\\\/#\\\/schema\\\/person\\\/0bc1494f46fc2a051c761322a80e0941\",\"name\":\"Ilona H\u00f6rath\",\"url\":\"https:\\\/\\\/digidem-bayern.de\\\/en\\\/author\\\/hoeratia\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt? - digiDEM Bayern","description":"Im Webinar \"digiDEM Bayern Science Watch LIVE\" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/digidem-bayern.de\/en\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/","og_locale":"en_US","og_type":"article","og_title":"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt? - digiDEM Bayern","og_description":"Im Webinar \"digiDEM Bayern Science Watch LIVE\" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.","og_url":"https:\/\/digidem-bayern.de\/en\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/","og_site_name":"digiDEM Bayern","article_publisher":"https:\/\/www.facebook.com\/digiDEMBayern\/","article_published_time":"2024-11-04T08:30:45+00:00","article_modified_time":"2025-01-14T08:15:14+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg","type":"image\/jpeg"}],"author":"Ilona H\u00f6rath","twitter_misc":{"Written by":"Ilona H\u00f6rath","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/#article","isPartOf":{"@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/"},"author":{"name":"Ilona H\u00f6rath","@id":"\/#\/schema\/person\/0bc1494f46fc2a051c761322a80e0941"},"headline":"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt?","datePublished":"2024-11-04T08:30:45+00:00","dateModified":"2025-01-14T08:15:14+00:00","mainEntityOfPage":{"@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/"},"wordCount":198,"commentCount":0,"publisher":{"@id":"\/#organization"},"image":{"@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/#primaryimage"},"thumbnailUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg","keywords":["Alzheimer","Alzheimer-Demenz","Amyloid-Hypothese","Antik\u00f6rper","Antik\u00f6rpertherapie","Demenz","Demenzerkrankung","Deutsche Alzheimer Gesellschaft","digidem","digidem Bayern","Digitales Demenzregister Bayern","MCI","monoklonale Antik\u00f6rper","Nebenwirkungen","Uniklinikum Erlangen","Webinar"],"articleSection":["Kommendes Webinar"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/","url":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/","name":"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt? - digiDEM Bayern","isPartOf":{"@id":"\/#website"},"primaryImageOfPage":{"@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/#primaryimage"},"image":{"@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/#primaryimage"},"thumbnailUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg","datePublished":"2024-11-04T08:30:45+00:00","dateModified":"2025-01-14T08:15:14+00:00","description":"Im Webinar \"digiDEM Bayern Science Watch LIVE\" behandeln Wissenschaftler ein Thema aus der Demenzforschung und stehen live f\u00fcr Fragen zur Verf\u00fcgung.","breadcrumb":{"@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/#primaryimage","url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg","contentUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg","width":1000,"height":563,"caption":"Foto: Shutterstock"},{"@type":"BreadcrumbList","@id":"https:\/\/digidem-bayern.de\/neue-medikamente-gegen-die-alzheimer-krankheit-ein-fortschritt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/digidem-bayern.de\/"},{"@type":"ListItem","position":2,"name":"Neue Medikamente gegen die Alzheimer-Krankheit \u2013 ein Fortschritt?"}]},{"@type":"WebSite","@id":"\/#website","url":"\/","name":"digiDEM Bavaria","description":"The digital dementia register in Bavaria researches and improves the structure of services for people with dementia and their relatives","publisher":{"@id":"\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"\/#organization","name":"digiDEM Bavaria","url":"\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"\/#\/schema\/logo\/image\/","url":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2022\/03\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png","contentUrl":"https:\/\/digidem-bayern.de\/wp-content\/uploads\/2022\/03\/cropped-Allgemeines_digiDEMLOGO-removebg-preview.png","width":612,"height":357,"caption":"digiDEM Bayern"},"image":{"@id":"\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/digiDEMBayern\/","https:\/\/x.com\/digidem_bayern","https:\/\/www.instagram.com\/digidem.bayern","https:\/\/www.linkedin.com\/company\/digidem-bayern\/"]},{"@type":"Person","@id":"\/#\/schema\/person\/0bc1494f46fc2a051c761322a80e0941","name":"Ilona H\u00f6rath","url":"https:\/\/digidem-bayern.de\/en\/author\/hoeratia\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-80x80.jpg",80,80,true],"medium":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-300x169.jpg",300,169,true],"medium_large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-768x432.jpg",768,432,true],"large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"1536x1536":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"2048x2048":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"trp-custom-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",18,10,false],"qubely_landscape":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"qubely_portrait":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-540x320.jpg",540,320,true],"qubely_thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-140x100.jpg",140,100,true],"post-thumbnail":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-622x350.jpg",622,350,true],"kahuna-featured":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-734x350.jpg",734,350,true],"kahuna-featured-lp":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"kahuna-featured-half":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-800x350.jpg",800,350,true],"kahuna-featured-third":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-512x350.jpg",512,350,true],"kahuna-lpbox-1":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x300.jpg",520,300,true],"kahuna-lpbox-2":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"demand-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"dddkt-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"ddiqc-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"ddtl-language-flag":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-36x36.jpg",36,36,true],"mailpoet_newsletter_max":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false],"kahuna-lpbox-3":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-520x350.jpg",520,350,true],"kahuna-featured-square":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545-512x512.jpg",512,512,true],"kahuna-featured-square-large":["https:\/\/digidem-bayern.de\/wp-content\/uploads\/2024\/11\/shutterstock_Lecanemab-Graessel-2237324545.jpg",1000,563,false]},"uagb_author_info":{"display_name":"Ilona H\u00f6rath","author_link":"https:\/\/digidem-bayern.de\/en\/author\/hoeratia\/"},"uagb_comment_info":1,"uagb_excerpt":"Echte Hilfe f\u00fcr Betroffene oder medialer Hype – was k\u00f6nnen wir von den neuen Medikamenten zur Behandlung der Alzheimer-Erkrankung wirklich erwarten? Weltweit f\u00fchren Fachexperten kontroverse Diskussionen \u00fcber die sogenannten monoklonalen Antik\u00f6rper, die f\u00fcr die Behandlung von leichten kognitiven Beeintr\u00e4chtigungen und Alzheimer-Demenz vorgesehen sind. Mit den Fakten aus der Forschung werden …","_links":{"self":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/39633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/comments?post=39633"}],"version-history":[{"count":2,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/39633\/revisions"}],"predecessor-version":[{"id":39637,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/posts\/39633\/revisions\/39637"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/media\/39631"}],"wp:attachment":[{"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/media?parent=39633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/categories?post=39633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/digidem-bayern.de\/en\/wp-json\/wp\/v2\/tags?post=39633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}